LEP and metabolic dysfunction-associated steatotic liver disease: Collectively, these data indicated that, in Mc4r-KO mice — a model of hyperphagic obesity without leptin deficiency in which hepatic DNL is increased to a lesser extent than in ob/ob mice — hepatic FASN deficiency ameliorated both NAFLD and diabetes.